Latest News about NVAX
Recent news which mentions NVAX
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
From Motley Fool
3 Sorry Pharma Stocks to Sell in February Before It’s Too Late
February 01, 2023
From InvestorPlace
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
From Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
3 Great Growth Stocks Down 20% or More to Buy Now
January 27, 2023
From Motley Fool
Tickers
NVAX
From Motley Fool
3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023
January 24, 2023
From Motley Fool
Here's the Worst Mistake Novavax Investors Can Make in 2023
January 20, 2023
From Motley Fool
China to start issuing new tourism passports as Lunar New Year approaches amid wave of COVID cases
January 18, 2023
Tickers
NVAX
From MarketWatch
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
From Motley Fool
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
From InvestorPlace
2 Down-on-Their-Luck Stocks That Could Go Parabolic
January 17, 2023
From Motley Fool
From Motley Fool
Tickers
NVAX
From Motley Fool
With This Big Transition Ahead, Is Novavax a Buy?
January 12, 2023
From Motley Fool
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money in 18 Months
January 11, 2023
From Motley Fool
NVAX Stock Alert: What to Know as Novavax Names New CEO
January 09, 2023
From InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
January 09, 2023
From InvestorPlace
Tickers
NVAX
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2023
From Benzinga
US Stocks On Track To Start 2023 On Upbeat Note: Investors Shrug Off Past Year's Dismal Show And Pin Hopes On A Rebound
January 03, 2023
From Benzinga
7 Sensational Stocks That Can Double Your Money in 2023
January 03, 2023
From Motley Fool
COVID-related ICU patients rise to 5-month high above 5,000—are new cases really falling?
December 30, 2022
From MarketWatch
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
From Motley Fool
Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates
December 30, 2022
Tickers
NVAX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.